Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot) "RASUNOA"

Completed

Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- age >= 18 years
- informed consent
- acute stroke or intracranial bleeding
- therapy with a new oral anticoagulant (Dabigatran®, Rivaroxaban®, Apixaban®, Edoxaban®)

Exclusion Criteria

- missing informed consent